Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C

CD44 CD44 variant 4 enzyme-linked immunosorbent assay epitope monoclonal antibody

Journal

Monoclonal antibodies in immunodiagnosis and immunotherapy
ISSN: 2167-9436
Titre abrégé: Monoclon Antib Immunodiagn Immunother
Pays: United States
ID NLM: 101590955

Informations de publication

Date de publication:
20 Mar 2024
Historique:
medline: 20 3 2024
pubmed: 20 3 2024
entrez: 20 3 2024
Statut: aheadofprint

Résumé

CD44 is a type I transmembrane glycoprotein and possesses various isoforms which are largely classified into CD44 standard (CD44s) and CD44 variant (CD44v) isoforms. Some variant-encoded regions play critical roles in tumor progression. However, the function of CD44 variant 4 (CD44v4)-encoded region has not been fully understood. Using peptide immunization, we developed an anti-CD44v4 monoclonal antibody, C

Identifiants

DOI: 10.1089/mab.2023.0022 PMID: 38507669
pubmed: 38507669
doi: 10.1089/mab.2023.0022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Hiroyuki Suzuki (H)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Mayuki Tawara (M)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Aoi Hirayama (A)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Nohara Goto (N)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Tomohiro Tanaka (T)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Mika K Kaneko (MK)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).

Yukinari Kato (Y)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
This paper was previously published in preprint.org (doi: 10.20944/preprints202311.0216.v1).
ORCID: 0000-0001-5385-8201

Classifications MeSH